Doctor profile · Federal record
Dr. David Kirakossian, M.D.
Rheumatology Physician (CMS: Rheumatology) · Internal Medicine Physician · Student in an Organized Health Care Education/Training Program · Student in an Organized Health Care Education/Training Program · Portland, OR
- NPI 1215399308
- Accepts Medicare
- MIPS 91.9 / 100 · 2023
- 10 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
9555 Sw Barnes RD Ste 150
Portland, OR 972256691
(503) 297-3384
fax (503) 297-0863 - Additional location
-
3181 Sw Sam Jackson Park RD
Portland, OR 972393098
(503) 494-8211 - Additional location
-
710 Lawrence Expy
Santa Clara, CA 950515173
(408) 851-3830
Credentials & registration
- NPI registered
- March 2016 — 10 yrs on file
- Profile last updated
- July 19, 2022
- Year of graduation
- 2016 — 10 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State licenses (2)
- Oregon #MD209272 · California #A150426
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1215399308. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
61,389
Distinct HCPCS
10
Medicare allowed
$928,675
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 24,950 | 57 | $13 | |
J3262 |
Injection, tocilizumab, 1 mg | 23,988 | 16 | $6 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 4,475 | 20 | $42 | |
J0897 |
Injection, denosumab, 1 mg | 4,020 | 58 | $23 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 2,750 | 30 | $33 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 312 | 168 | $129 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 290 | 123 | $67 | |
J3489 |
Injection, zoledronic acid, 1 mg | 150 | 30 | $9 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 131 | 47 | $30 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 104 | 47 | $139 |
In context: peer comparison
Among 13 peers in Portland Rheumatology Physician, average services per provider: 2,412. This provider delivers 25× the peer median.Medicare Part D · 2023
Top prescriptions
Total claims
1,419
Patients
458
Total drug cost
$755,413
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 345 | 126 | $4,585 |
| Methotrexate (Methotrexate Sodium) | Brand | 276 | 94 | $14,738 |
| Hydroxychloroquine Sulfate | Generic | 225 | 81 | $18,877 |
| Leflunomide | Generic | 115 | 41 | $9,039 |
| Alendronate Sodium | Generic | 80 | 25 | $818 |
| Enbrel Sureclick (Etanercept) | Brand | 60 | 0 | $442,877 |
| Sulfasalazine Dr (Sulfasalazine) | Brand | 48 | 22 | $4,340 |
| Sulfasalazine | Generic | 45 | 19 | $2,131 |
| Allopurinol | Generic | 39 | 13 | $864 |
| Folic Acid | Generic | 36 | 15 | $258 |
Hospital affiliations
Frequently asked questions
What is Dr. David Kirakossian's medical specialty?
Dr. David Kirakossian practices Rheumatology Physician in Portland, OR.
Where does Dr. David Kirakossian practice?
Dr. David Kirakossian practices at 9555 Sw Barnes RD Ste 150, Portland, OR 972256691. Office phone: 5032973384.
What is Dr. David Kirakossian's NPI?
Dr. David Kirakossian's National Provider Identifier (NPI) is 1215399308, issued by NPPES.
Does Dr. David Kirakossian accept Medicare assignment?
Yes. Dr. David Kirakossian accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. David Kirakossian commonly perform?
Top Medicare-reported procedures in 2023: Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129). Source: CMS Medicare Physician & Other Practitioners file.